Prosecution Insights
Prosecution Insights
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 61 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (25%) |
| §103 only | 3 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COHEN, STEFANIE J | 1 | 75.3% | +2.3% |
| WILSON, JERICA KATLYNN | 1 | 61.5% | +38.7% |
| MACCAGNO, PIERRE L | 1 | 23.0% | +31.5% |
| NOTTINGHAM, KYLE GREGORY | 1 | 59.3% | +34.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18766050 | SYSTEM AND METHOD FOR DIAGNOSTICS AND FINDING TREATMENTS FOR MILD COGNITIVE IMPAIRMENT, DEMENTIAS AND NEURODEGENERATIVE DISEASES | MACCAGNO, PIERRE L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16276004 | Suppression and Inhibition of CDC25B with Safranal-Based Formulations | NOTTINGHAM, KYLE GREGORY | 21d |
| 18925790 | NEW USE OF RECA INHIBITOR AND DERIVATIVE COMPOUNDS FOR CANCER TREATMENT | WILSON, JERICA KATLYNN | — |
| 18766050 | SYSTEM AND METHOD FOR DIAGNOSTICS AND FINDING TREATMENTS FOR MILD COGNITIVE IMPAIRMENT, DEMENTIAS AND NEURODEGENERATIVE DISEASES | MACCAGNO, PIERRE L | — |
| Art Unit | Apps |
|---|---|
| 1621 | 2 |
| 1732 | 1 |
| 3687 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19455359 | V2C@V2O5/TiO2 COMPOSITE PHOTOCATALYST, PREPARATION METHOD, AND APPLICATION THEREOF | COHEN, STEFANIE J | 1732 | §103 | Non-Final OA | — | Pending | Jan 21, 2026 |
| 18925790 | NEW USE OF RECA INHIBITOR AND DERIVATIVE COMPOUNDS FOR CANCER TREATMENT | WILSON, JERICA KATLYNN | 1621 | §103 | Non-Final OA | — | Pending | Oct 24, 2024 |
| 18766050 | SYSTEM AND METHOD FOR DIAGNOSTICS AND FINDING TREATMENTS FOR MILD COGNITIVE IMPAIRMENT, DEMENTIAS AND NEURODEGENERATIVE DISEASES | MACCAGNO, PIERRE L | 3687 | §101 | Final Rejection | — | Pending | Jul 08, 2024 |
| 16276004 | Suppression and Inhibition of CDC25B with Safranal-Based Formulations | NOTTINGHAM, KYLE GREGORY | 1621 | §103Other | Final Rejection | 21d | Pending | Feb 14, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial